Epoch 39 - Sorry But...Biotech Does Not Scale

Venture Capital Math, Optimal Fund Size, and Returns

Oct 02, 2022

∙ Paid

Welcome to the 52 NEW Biotech Innovators who have joined us this month! If you haven’t subscribed, join the 793 researchers, investors, operators, academics, clinicians and entrepreneurs by subscribing here:

Hello Avatar! Welcome back for another week of biotech analysis. This week we are going to dig into venture capital math and exactly how returns wor…

Continue reading this post for free, courtesy of BowTiedBiotech.

Or purchase a paid subscription.